Pacific Biosciences of California Inc

Pacific Biosciences of California Inc (PACB) News & Events

$1.730

-0.203 (-11.73%)At close

PACB News

PACB Events

10/19 10:00

PacBio and Verily Health Announce Strategic Collaboration

PacBio and Verily Health announced a multi-year strategic collaboration to integrate PacBio HiFi sequencing with Verily Health's governed data and AI platform. The collaboration will link PacBio sequencing workflows to Verily Pre, combining long-read genomic data with real-world clinical data at population scale. The resulting AI-ready clinico-genomic datasets will support biomedical discovery efforts and AI model training and deployment.

10/6 10:00

PacBio and TychoBio Collaborate to Generate Full-Length RNA Data

PacBio and TychoBio announced a collaboration to generate full-length RNA data that TychoBio will use to train models for RNA therapy design. Under the terms of the agreement, TychoBio plans to use PacBio HiFi sequencing and Kinnex long-read RNA sequencing to generate data from more than 10,000 samples, building large-scale datasets linking the design of steric blocking antisense oligonucleotides to their effects across the transcriptome, with plans to expand the approach to siRNA and other RNA-targeting compounds. TychoBio will test candidate RNA therapies and use PacBio sequencing to measure how each one changes the transcriptome across multiple cell types. Those results will become training data for models designed to predict which compounds are most likely to work, how long their effects may last, and where unintended effects may occur.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading